Human cytomegalovirus (HCMV) is a herpesvirus that infects between 40% and 95% of the
population worldwide, usually without symptoms. The host immune response keeps the …

Human cytomegalovirus (HCMV) is a herpesvirus that alternates lytic and latent infection,
infecting between 40 and 95% of the population worldwide, usually without symptoms …

The accurate identification and prioritization of antigenic peptides is crucial for the
development of personalized cancer immunotherapies. Publicly available pipelines to …

Immune evasion represents a crucial milestone in the progression of cancer and serves as
the theoretical foundation for tumor immunotherapy. In this study, we reveal a negative …

Abstract The Epstein-Barr Virus (EBV) is a gamma-herpesvirus involved with a variety of
human cancers, notably the endemic Burkitt lymphoma and nasopharyngeal carcinoma. In …

Approximately 15–20% of global cancer cases are attributed to virus infections. Oncoviruses
employ various molecular strategies to enhance replication and persistence. Human …

Viruses lack essential living system, so they must hijack host cell metabolism for its survival
and reproduction. Interestingly, the metabolic reprogramming induced by oncovirus is critical …

High-risk human papillomavirus (HPV)-driven cancers represent a major health concern
worldwide. Despite the constant effort to develop and promote vaccination against HPVs …

Cancer progression is critically associated with modulation of host cell signaling pathways.
Activator protein‐1 (AP‐1) signaling is one such pathway whose deregulation renders the …

Viral control of programmed cell death relies in part on the expression of viral analogs of the
B-cell lymphoma 2 (Bcl2) protein known as viral Bcl2s (vBcl2s). vBcl2s control apoptosis by …